Merck and NGM Bio extend strategic collaboration to 2022
KENILWORTH, N.J. — Merck and NGM Biopharmaceuticals, Inc. (NGM) Wednesday announced that Merck has exercised its option to extend the research phase of the companies’ broad, strategic collaboration for an additional two-year period from March 2020 to March 2022. The collaboration, originally announced in February 2015, is focused on discovering, developing and commercializing novel biologic therapeutics across
